United Asset Strategies’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,148
| Closed | -$804K | – | 232 |
|
|
2020
Q4 | $804K | Sell |
5,148
-80
| -2% | -$12.5K | 0.13% | 116 |
|
|
2020
Q3 | $598K | Buy |
5,228
+1,094
| +26% | +$125K | 0.11% | 121 |
|
|
2020
Q2 | $464K | Sell |
4,134
-169
| -4% | -$19K | 0.09% | 133 |
|
|
2020
Q1 | $386K | Sell |
4,303
-282
| -6% | -$25.3K | 0.1% | 135 |
|
|
2019
Q4 | $496K | Buy |
4,585
+105
| +2% | +$11.4K | 0.1% | 150 |
|
|
2019
Q3 | $439K | Sell |
4,480
-7,017
| -61% | -$688K | 0.1% | 140 |
|
|
2019
Q2 | $567K | Buy |
+11,497
| New | +$567K | 0.13% | 127 |
|